Surface-bound plasmin induces selective proteolysis of insulin-like- growth-factor (IGF)-binding protein-4 (IGFBP-4) and promotes autocrine IGF- II bio-availability in human colon-carcinoma cells

International Journal of Cancer

Volumn 72, Issue 5, 1997, Pages 835-843

  Remacle Bonnet, Maryse M ^a   Garrouste, Françoise L ^a   Pommier, Gilbert J ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMIN; PLASMINOGEN; PROTEINASE; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 6; UROKINASE;

ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ADENOCARCINOMA; APROTININ; BLOTTING, WESTERN; COLONIC NEOPLASMS; CULTURE MEDIA, CONDITIONED; ENDOPEPTIDASES; EXTRACELLULAR MATRIX; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR II; PLASMIN; PLASMINOGEN; TUMOR CELLS, CULTURED;

EID: 0030818009     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970904)72:5<835::AID-IJC21>3.0.CO;2-6     Document Type: Article

References (27)

1. ANGELLOZ-NICOUD, P. and BINOUX, M., Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF-binding protein-3 protease system in a human prostate-carcinoma cell line (PC-3). Endocrinology, 136, 5485-5792 (1995).
2. ARAI, T., PARKER, A., BUSBY, JR., W. and CLEMMONS, D.R., Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like-growth-factor-binding protein complexes. J. biol. Chem., 269, 20388-20393 (1994).
3. BLAT, C., VILLAUDY, J. and BINOUX, M., In vivo proteolysis of serum insulin-like-growth-factor (IGF)-binding protein-3 results in increased availability of IGF to target cells. J. clin. Invest., 93, 2286-2290 (1994).
4. BOOTH, B.A., BOES, M., ANDRESS, D.L., DAKE, B.L., KIEFER, M.C., MAACK, C., LINHARDT, R.J., BAR, K., CALDWELL, E.E.O., WEILER, J. and BAR, R.S., IGFBP-3 and IGFBP-5 association with endothelial cells: role of c-terminal heparin-binding domain. Growth Regul., 5, 1-17 (1995).
5. CAMPBELL, P.G., NOVAK, J.F., YANOSICK, T.B. and MCMASTER, J.H., Involvement of the plasmin system in dissociation of the insulin-like-growth-factor-binding protein complex. Endocrinology, 130, 1401-1412 (1992).
6. CHERNAUSEK, S.D., SMITH, C.E., DUFFIN, K.L., BUSBY, W.H., WRIGHT, G. and CLEMMONS, D.R., Proteolytic cleavage of insulin-like-growth-factor-binding protein 4 (IGFBP-4). J. biol. Chem., 270, 11377-11382 (1995).
7. CONOVER, C.A., DURHAM, S.K., ZAPF, J., MASIARZ, F.R. and KIEFER, M.C., Cleavage analysis of insulin-like-growth-factor (IGF)-dependent IGF-binding-protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants. J. biol. Chem., 270, 4395-4400 (1995).
8. HOSSENLOPP, P., SEGOVIA, B., LASSARRE, C., ROGHANI, M., BREDON, M. and BINOUX, M., Evidence of enzymatic degradation of insulin-like-growth-factor-binding proteins in the 150-K complex during pregnancy. J. clin. endocrinol. Metab., 71, 797-805 (1990).
9. JONES, J.I. and CLEMMONS, D.R., Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev., 16, 3-34 (1995).
10. JONES, J.I., GOCKERMAN, A., BUSBY, W.H., CAMACHO-HUBNER, C. and CLEMMONS, D.R., Extracellular matrix contains insulin-like-growth-factor-binding protein-5: potentiation of the effects of IGF-I. J. Cell Biol., 121, 679-687 (1993).
11. KOUTSILIERIS, M. and POLYCHRONAKOS, C., Proteinolytic activity against IGF-binding proteins involved in the paracrine interactions between prostate adenocarcinoma cells and osteoblasts. Anticancer Res., 12, 905-910 (1992).
12. LALOU, C., SILVE, C., ROSATO, R., SEGOVIA, B. and BINOUX, M., Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding-protein-3 production and proteolysis in human osteosarcoma cells Endocrinology, 135, 2318-2326 (1994).
13. PARK, J.H.Y., CORKINS, M.R., VANDERHOOF, J.A., CARUSO, N.M., HRBEK, M.J., SCHAFFER, B.S., SLENTZ, D.H., MCCUSKER, R.H. and MACDONALD, R.G., Expression of insulin-like growth factor-II and insulin-like-growth-factor-binding proteins during Caco-2-cell proliferation and differentiation. J. cell. Physiol., 166, 396-406 (1996).
14. PöLLäNEN, J., STEPHENS, R.W. and VAHERI, A., Directed plasminogen activation at the surface of normal and malignant cells. Advanc. Cancer Res., 57, 273-328 (1991).
15. POMMIER, G.J., GARROUSTE, F.L., EL ATIQ, F., ROCCABIANCA, M., MARVALDI, J.L. and REMACLE-BONNET, M.M., Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic-adenocarcinoma cell line. Cancer Res., 52, 3182-3188 (1992).
16. PYKE, C., KRISTENSEN, P., RALFKIAER, E., GRONDHAL-HANSEN, J., ERIKSEN, J., BLASI, F. and DANO, K., Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Amer. J. Pathol., 138, 1059-1067 (1991).
17. REITER, L.S., KRUITHOF, E.K.O., CAJOT, J.F. and SORDAT, B., The role of urokinase receptor in extracellular-matrix degradation by HT29 human colon-carcinoma cells. Int. J. Cancer, 53, 444-450 (1993).
18. REMACLE-BONNET, M., GARROUSTE, F., EL ATIQ, F., MARVALDI, J. and POMMIER, G., Cell polarity of the insulin-like-growth-factor system in human intestinal epithelial cells. J. clin. Invest., 96, 192-200 (1995).
19. REMACLE-BONNET, M., GARROUSTE, F., EL ATIQ, F., ROCCABIANCA, M., MARVALDI, J. and POMMIER, G., Des-(1-3)-IGF-I, an insulin-like-growth-factor analog used to mimic a potential IGF-II autocrine loop, promotes the differentiation of human colon-carcinoma cells. Int. J. Cancer, 52, 910-917 (1992a).
20. REMACLE-BONNET, M.M., CULOUSCOU, J.M., GARROUSTE, F.L., RABENANDRASANA, C., MARVALDI, J.L. and POMMIER, G.J., Expression of type-I, but not type-II insulin-like-growth-factor receptor on both undifferentiated and differentiated HT29 human colon-carcinoma cell line. J. clin. endocrinol. Metab., 75, 609-616 (1992b).
21. RUOSLAHTI, E. and YAMAGUCHI, Y., Proteoglycans as modulators of growth-factor activities. Cell, 64, 867-869 (1991).
22. SATO, Y. and RIFKIN, D.B., Inhibition of endothelial-cell movement by pericytes and smooth-muscle cells: activation of a latent transforming-growth-factor-β1-like molecule by plasmin during co-culture. J. Cell Biol., 109, 309-315 (1989).
23. SINGH, P., DAI, B., DHRUVA, B. and WIDEN, S.G., Episomal expression of sense and anti-sense insulin-like-growth-factor (IGF)-binding protein-4 complementary DNA alters the mitogenic response of a human colon-cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-I. Cancer Res., 54, 6563-6570 (1994).
24. SINGH, P., DAI, B., YALLAMPALLI, U., LU, X. and SCHROY, P.C., Proliferation and differentiation of a human colon-cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF-binding protein-4: role of IGF-II. Endocrinology, 137, 1764-1774 (1996).
25. SINGH, P. and RUBIN, N., Insulin-like growth factors and binding proteins in colon cancer. Gastroenterology, 105, 1218-1237 (1993).
26. WU, X., FAN, Z., MASUI, H., ROSEN, N. and MENDELSOHN, J., Apoptosis induced by an anti-epidermal growth-factor-receptor monoclonal antibody in a human colorectal-carcinoma cell line and its delay by insulin. J. clin. Invest., 95, 1897-1905 (1995).
27. ZARRILLI, R., ROMANO, M., PIGNATA, S., CASOLA, S., BRUNI, C.B. and ACQUAVIVA, A.M., Constitutive insulin-like-growth-factor-II expression interferes with the enterocyte-like differentiation of CaCo-2 cells. J. biol. Chem., 271, 8108-8114 (1996).